Warning: This security is no longer trading.
Menlo Therapeutics Inc. has acquired Foamix Pharmaceuticals
Foamix Pharmaceuticals Ltd. - Ordinary Shares (FOMX): Price and Financial Metrics
FOMX Price/Volume Stats
| Current price | $2.99 | 52-week high | $4.84 |
| Prev. close | $3.24 | 52-week low | $1.97 |
| Day low | $2.90 | Volume | 1,930,800 |
| Day high | $3.44 | Avg. volume | 596,231 |
| 50-day MA | $3.94 | Dividend yield | N/A |
| 200-day MA | $3.16 | Market Cap | 184.13M |
FOMX Stock Price Chart Interactive Chart >
Foamix Pharmaceuticals Ltd. - Ordinary Shares (FOMX) Company Bio
Foamix Pharmaceuticals is a clinical-stage specialty pharmaceutical company focused on developing and commercializing its proprietary minocycline foam for the treatment of acne and other skin conditions. The company was founded in 2003 and is based in Rehovot, Israel.
FOMX Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
FOMX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2024 | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |